Published in Cancer on June 01, 1977
Physicians' recommendations for mammography: do tailored messages make a difference? Am J Public Health (1994) 3.54
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health (1989) 2.93
Patterns of preventive practice in New Brunswick. Can Med Assoc J (1985) 2.90
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study. BMJ (1990) 2.51
The war on cancer--failure of therapy and research: discussion paper. J R Soc Med (1991) 2.45
Behavioral risk factors: a comparison of Latinos and non-Latino whites in San Francisco. Am J Public Health (1994) 2.17
Management of female breast disease by Southampton general practitioners. Br Med J (1980) 2.03
Evaluation of public health preschool child developmental screening: the process and outcomes of a community program. Am J Public Health (1987) 1.91
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ (2001) 1.74
Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg (1988) 1.55
Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health (Larchmt) (2011) 1.53
Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer (1991) 1.42
Breast self-examination: an adjuvant to early cancer detection. Am J Public Health (1981) 1.40
The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med (2010) 1.39
Repeated screening for breast cancer. J Epidemiol Community Health (1984) 1.37
Some thoughts on why women don't do breast self-examination. Can Med Assoc J (1983) 1.34
Mammographic signs as risk factors for breast cancer. Br J Cancer (1982) 1.28
Present status of breast cancer screening. Can Med Assoc J (1977) 1.26
Prospects for eliminating racial differences in breast cancer survival rates. Am J Public Health (1982) 1.22
Estimated benefits and risks of screening for breast cancer. Can Med Assoc J (1981) 1.20
Breast cancer: views of general practitioners on its detection and treatment. J R Coll Gen Pract (1984) 1.20
Choosing quality of care measures based on the expected impact of improved care on health. Health Serv Res (1992) 1.17
Breast self-examination competency: an analysis of self-reported practice and associated characteristics. Am J Public Health (1983) 1.16
Cancer prevention research - then and now. Nat Rev Cancer (2009) 1.12
Recent trends in breast surgery in the United States and United Kingdom. Br Med J (Clin Res Ed) (1986) 1.12
Time for evidence-based screening? J R Soc Med (1998) 1.08
Arguments against mammography screening continue to be based on faulty science. Oncologist (2014) 1.00
Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol (2014) 0.98
A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening. Stat Med (2013) 0.97
Evaluation of a proposed breast cancer screening regimen. BMJ (1988) 0.93
Stage III carcinoma of the breast. A detailed analysis. Ann Surg (1980) 0.88
Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. GIVIO (Interdisciplinary Group for Cancer Care Evaluation). J Epidemiol Community Health (1991) 0.86
Hospital work load produced by breast-cancer screening programme run by trained non-medical staff. Br Med J (1980) 0.86
The impact of the National Breast Screening Programme on the incidence of breast cancer in a UK health district. J R Soc Med (1993) 0.84
The prevention and control of chronic diseases: reducing unnecessary deaths and disability--a conference report. Public Health Rep (1987) 0.84
Breast-cancer screening. Can Fam Physician (1987) 0.83
Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age. Curr Oncol (2014) 0.83
Increase in mammography detected breast cancer over time at a community based regional cancer center: a longitudinal cohort study 1990-2005. BMC Cancer (2008) 0.83
Evaluation of the effectiveness of mass screening for uterine cancer in Japan: the potential years of life lost. Environ Health Perspect (1990) 0.80
Canadian national breast cancer screening study. Can Med Assoc J (1980) 0.80
The national breast screening study: an opportunity for family physicians. Can Fam Physician (1982) 0.80
Abnormal mammograms with no lump. Br Med J (Clin Res Ed) (1982) 0.80
Rational and irrational issues in breast cancer screening. Cancers (Basel) (2011) 0.80
Consent for mastectomy. Br Med J (1980) 0.79
Breast cancer beliefs of women participating in a television-promoted mammography screening project. Public Health Rep (1993) 0.77
State of the art of current modalities for the diagnosis of breast lesions. Eur J Nucl Med Mol Imaging (2004) 0.76
Mode of detection and secular time for ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 0.76
The global challenge of reducing breast cancer mortality. Oncologist (2013) 0.75
[Not Available]. Can Fam Physician (1981) 0.75
A reader's guide to the evaluation of screening studies. Postgrad Med J (1996) 0.75
The canadian national breast screening study: why it deserves support. Can Fam Physician (1982) 0.75
Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening. PLoS One (2016) 0.75
The role of the obstetrician-gynecologist in the management of breast lesions. J Natl Med Assoc (1983) 0.75
The need and value of breast self-examination. J Natl Med Assoc (1988) 0.75
Breast disease in women under thirty--ten year review and assessment of clinical screening. Ulster Med J (1982) 0.75
A comparison of breast self-examination and clinical examination. J Natl Med Assoc (1994) 0.75
Some obstacles to the evaluation and effective performance of health appraisals. West J Med (1984) 0.75
Film-screen mammography: comparison of views. J Natl Med Assoc (1989) 0.75
Canadian national breast cancer screening study. Can Med Assoc J (1980) 0.75
Back-up for screening for breast cancer. Br Med J (1978) 0.75
Response: Reading between the lines of cancer screening trials: using modeling to understand the evidence. Med Care (2013) 0.75
Screening for breast cancer. Report from Edinburgh Breast Screening Clinic. Br Med J (1978) 0.75
Screening for disease in asymptomatic patients. Trans Am Clin Climatol Assoc (1988) 0.75
[Not Available]. Can Fam Physician (1982) 0.75
BSE versus dogmatism. Am J Public Health (1982) 0.75
Breast cancer detection. West J Med (1986) 0.75
Assessment of self-reward strategies for maintenance of breast self-examination. J Behav Med (1998) 0.75
Breast cancer screening. A brief historical review. Breast Cancer Res Treat (1991) 0.75
Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Comprehensive drug surveillance. JAMA (1970) 2.92
Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80
Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53
Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The search for risk factors in breast cancer. Am J Public Health Nations Health (1968) 2.16
The economic impact of traumatic injuries. One-year treatment-related expenditures. JAMA (1988) 2.15
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
The Abbreviated Injury Scale and Injury Severity Score. Levels of inter- and intrarater reliability. Med Care (1985) 2.11
Methyl-coenzyme M, an intermediate in methanogenic dissimilation of C1 compounds by Methanosarcina barkeri. J Bacteriol (1980) 2.11
Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Prepregnant weight in relation to risk of neural tube defects. JAMA (1996) 2.02
Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA (1966) 2.00
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med (1990) 1.95
Reproductive factors and risk of myocardial infarction. Am J Epidemiol (1992) 1.94
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Multivitamin supplementation and risk of birth defects. Am J Epidemiol (1999) 1.91
Noncontraceptive estrogens and myocardial infarction in young women. JAMA (1980) 1.88
Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr (1985) 1.87
End result measurements of quality of medical care. Milbank Mem Fund Q (1967) 1.87
Relevance of correlates of infant deaths for significant morbidity at 1 year of age. Am J Obstet Gynecol (1980) 1.85
Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health (1968) 1.85
Vasectomy and the risk of prostate cancer. Am J Epidemiol (1990) 1.84
Like mother, like child: intergenerational patterns of age at first birth and associations with childhood and adolescent characteristics and adult outcomes in the second generation. Dev Psychol (1998) 1.81
Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry (1987) 1.81
Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med (1983) 1.80
Patterns of medical use by the indigent aged under two systems of medical care. Am J Public Health Nations Health (1967) 1.80
Ventricular premature beats and mortality after myocardial infarction. N Engl J Med (1977) 1.79
Calcium channel blockers and the risk of cancer. JAMA (1998) 1.78
Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol (1989) 1.76
Stature and the risk of myocardial infarction in women. Am J Epidemiol (1990) 1.73
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Validation of an in vitro biofilm model of supragingival plaque. J Dent Res (2001) 1.73
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
"Low yield" cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med (1989) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Value of mammography in reduction of mortality from breast cancer in mass screening. Am J Roentgenol Radium Ther Nucl Med (1973) 1.65
Breast cancer and oral contraceptive use. Am J Epidemiol (1984) 1.64
Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA (1981) 1.64
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med (1978) 1.62
Clinical outcomes resulting from telemedicine interventions: a systematic review. BMC Med Inform Decis Mak (2001) 1.62
Lead time gained by diagnostic screening for breast cancer. J Natl Cancer Inst (1968) 1.61
Comparisons of poverty and nonpoverty groups on dental status, needs, and practices. J Public Health Dent (1975) 1.61
Adequacies and inadequacies of breast examinations by physicians. Cancer (1969) 1.60
Designing a community study of moderately to severely disabled older women: the Women's Health and Aging Study. Ann Epidemiol (1999) 1.59
Rehospitalization in the first year of life for high-risk survivors. Pediatrics (1980) 1.57
A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. J Clin Epidemiol (1998) 1.57
Importation of dogs into the United States: risks from rabies and other zoonotic diseases. Zoonoses Public Health (2008) 1.57
Closure of short, wide patent ductus arteriosus with cardiopulmonary bypass and balloon occlusion. Ann Thorac Surg (1998) 1.57
Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol (1974) 1.56
High-risk young mothers: infant mortality and morbidity in four areas in the United States, 1973-1978. Am J Public Health (1984) 1.56
Physical inactivity as a lethal factor in myocardial infarction among men. Circulation (1966) 1.55
Endometrial cancer and age at last delivery: evidence for an association. Am J Epidemiol (1991) 1.55
Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann Neurol (2001) 1.55
Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood (1997) 1.55
Risk factors for breast cancer. Am J Epidemiol (1983) 1.54
Cancer preventive screening behavior among elderly women. Prev Med (1982) 1.53
Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med (1977) 1.53
Reserpine use in relation to breast cancer. Lancet (1974) 1.51
Anticonvulsants and parental epilepsy in the development of birth defects. Lancet (1976) 1.51
Detection and management of mental health problems of older patients by primary care providers. JAMA (1987) 1.50
Episodes of illness and access to care in the inner city: a comparison of HMO and non-HMO populations. Health Serv Res (1976) 1.50
Very high mutation rate in offspring of Chernobyl accident liquidators. Proc Biol Sci (2001) 1.49
Proceedings: Changes in 5-year breast cancer mortality in a breast cancer screening program. Proc Natl Cancer Conf (1972) 1.49
Monitoring clinical research: an obligation unfulfilled. CMAJ (1995) 1.49